Similar Articles
331 Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score
332 Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
333 Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
334 Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
335 Novel prognostic factors after radical resection of hepatocellular carcinoma: Updating an old issue
336 Risk factors for recurrence of common bile duct stones after surgical treatment and effect of ursodeoxycholic acid intervention
337 Comparison of different preoperative objective nutritional indices for evaluating 30-d mortality and complications after liver transplantation
338 Predictive value of NLR, Fib4, and APRI in the occurrence of liver failure after hepatectomy in patients with hepatocellular carcinoma
339 Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma
340 What are the changes in the hotspots and frontiers of microRNAs in hepatocellular carcinoma over the past decade?
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA